Top 5 Blue Chip Stocks To Buy Right Now

Investors can add all sorts of investments to an IRA, but many financial advisors will suggest sticking with conservative dividend stocks. The reason is simple — blue chip income generators generally bounce back from big market crashes, and the compounding effect of reinvested dividends can deliver massive returns over several decades.

At first glance, tobacco giant Altria (NYSE:MO) seems like a great stock for an IRA. Its flagship Marlboro brand dominates the U.S. market, it pays a hefty forward dividend yield of 3.4%, and it’s hiked that dividend every year since it spun off itsoverseas business as Philip Morris International (NYSE:PM) in 2008. But if you gaze further into Altria’s future, you’ll realize that it’s not a great long-term pick for your IRA at all.

Image source: Getty Images.

Why Altria seems like a good IRA stock

Altria shares have rallied 20% over the past 12 months, outperforming Philip Morris’ 15% rally but slightly underperforming the S&P 500’s 25% gain. Much of that growth can be attributed to two factors — a flight to high-yielding dividend stocks in a low interest rate environment and Altria’s purely domestic business insulating it from the currency headwinds which gobbled up Philip Morris’ overseas gains.

Top 5 Blue Chip Stocks To Buy Right Now: Apache Corporation(APA)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).

  • [By WWW.THESTREET.COM]

    Cramer and the Action Alerts PLUS team say they still believe in their embattled Permian names, Cimarex (XEC) and Apache (APA) , both of which have benefited from a slow rotation in recent weeks. These names can produce and profit here. Schlumberger (SLB) remains best in class and Magellan Midstream Partners just might be the best way to play oil given that the pipelines will be needed to transport the new wave of oil able to be drawn out of the ground from increasingly efficient American producers. Get in on the discussion by getting a free trial subscription to Action Alerts PLUS.

  • [By WWW.THESTREET.COM]

    Cramer and the AAP team are detailing their outlook for portfolio energy names Apache (APA) and Cimarex (XEC) . Find out what they’re telling their investment club members with a free trial subscription to Action Alerts PLUS.

  • [By Chris Lange]

    Apache Corp. (NYSE: APA) fourth-quarter results are scheduled for Thursday. The consensus forecast is for $0.22 in EPS on $1.55 billion in revenue. Shares were trading at $38.11. The consensus price target is $50.43. The 52-week range is $35.70 to $56.51.

  • [By Paul Ausick]

    Apache Corp. (NYSE: APA) dropped about 7.3% Thursday to post a new 52-week low of $34.50. Shares closed at $37.20 on Wednesday and the stock’s 52-week high is $55.23. Volume was over 11 million, about three times the daily average of around 3.9 million. The company reported quarterly results this morning, but investors were not impressed.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Apache Corp. (NYSE: APA) which traded down over 7% at $42.51. The stocks 52-week range is $38.14 to $69.00. Volume was over 14 million versus the daily average of 3.4 million shares.

Top 5 Blue Chip Stocks To Buy Right Now: eHealth Inc.(EHTH)

Advisors’ Opinion:

  • [By Lisa Levin]

    eHealth, Inc. (NASDAQ: EHTH) was down, falling around 32 percent to $9.53. eHealth reported a Q2 net loss of $0.5 million, versus a year-ago net income of $5.8 million. The company also reported weak quarterly revenue.

Top 5 Blue Chip Stocks To Buy Right Now: Bayer Aktiengesellschaft (BAYRY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    You can torture the data many ways, of course, and there were some pharma price increases in the US, but apparently, they were not especially large. What hurt were discounting, especially for Xarelto, a Bayer (OTCPK:BAYRY) oral anticoagulant which JNJ markets in the US; and the diabetes Invokana line.

  • [By Todd Campbell]

    Nektar Therapeutics is working with Bayer AG (NASDAQOTH:BAYRY) on an inhaledversion of Amikacin, an anti-bacterial that if successful in trials could be used alongside standard of care to treat gram-negative pneumonia in intubated and mechanically ventilated patients. If it’s eventually approved in the U.S., Nektar Therapeutics will receive a flat 30% royalty on sales. It’s also working with Bayer on an inhaled powder formulation of Cipro that could be used to treat chronic lung infections in cystic fibrosis patients. Top-line phase 3 results on both drugs should be available this year.

  • [By SEEKINGALPHA.COM]

    The Regeneron press release in November for its Q3 2017 financial and operating results reaffirmed Eylea’s full year 2017 U.S. net product sales growth of approximately 10% over 2016, which could be about $1 billion. From our model, we see the Q4 total revenues for Eylea, excluding sales outside the United States from Regeneron’s collaborative partner Bayer AG (OTCPK:BAYRY), of $1.2 billion, or a 17% increase year-on-year. REGN stock has a forward P/E ratio of 21.83 as of December 8, 2017, while the current trailing P/E is 34.57.

  • [By SEEKINGALPHA.COM]

    This type of spin-off is not uncommon among German companies, as they streamline their portfolios to focus on the where they have more competitive advantages in the long term. For instance, in the recent past, Siemens (OTCPK:SIEGY) has split out Osram (OTC:OSAGY) and Bayer (OTCPK:BAYRY) has performed the spin-off of Covestro (OTCPK:CVXTY), something that Rheinmetall is likely to do in the near future because its auto unit has reached peak margins, and therefore this is the best time to spin-off the business.

  • [By SEEKINGALPHA.COM]

    Rivaroxaban was initially developed by Janssen, a subsidiary of Johnson & Johnson (NYSE:JNJ). It later entered an agreement with Bayer (OTCPK:BAYRY) to jointly complete the development process in 2005.

  • [By ]

    Bayer AG (BAYRY) also rose 4.13% to 97.29 on reports that its mega-merger with Monsanto Co. (MON) would likely be approved by the Department of Justice. The Wall Street Journal reported that the companies have agreed additional asset sales.

Top 5 Blue Chip Stocks To Buy Right Now: Williams-Sonoma Inc.(WSM)

Advisors’ Opinion:

  • [By Steve Symington] Williams-Sonoma(NYSE:WSM)announced better-than-expected fiscal fourth-quarter 2016 results Wednesday after the market closed. But that doesn’t mean the Pottery Barn parent was without its challenges over the key holiday period. Let’s take a closer look at how Williams-Sonoma capped the year, as well as what investors can expect from the company going forward.

    Image source: Williams-Sonoma/Pottery Barn via BusinessWire.

  • [By Peter Graham]

    A long term performance chart shows shares of RH back around their all time highs while the performance of other furniture or home d茅cor retailers likemid capBed Bath & Beyond Inc (NASDAQ: BBBY), mid cap Williams-Sonoma, Inc (NYSE: WSM) and small capPier 1 Imports Inc (NYSE: PIR) have largelydrifted downward or sideways for at least a year:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Pier 1 Imports and mid cap Bed Bath & Beyond Inc (NASDAQ: BBBY) underperforming while mid capWilliams-Sonoma, Inc (NYSE: WSM)isabove breakeven levels andsmallcap Restoration Hardware Holdings Inc (NYSE: RH)is once again performing well (but with considerable volatility):

  • [By Peter Graham]

    Mid cap home products retailerWilliams-Sonoma, Inc (NYSE: WSM) reported Q2 2017 earnings after the Wednesday market close with results exceeding Wall Street expectations. Net revenues grew 3.7% to $1.202 billion versus $1.159 billion with comparable brand revenue growth of 2.8% on top of 0.6% in Q2 2016:

  • [By Peter Graham]

    A long term performance chart shows mid cap Bed Bath & Beyond in a steady decline since around early 2015 while small capPier 1 Imports Inc (NYSE: PIR)has performed worst,small capRestoration Hardware Holdings Inc (NYSE: RH) is back up amidst volatility andmid capWilliams-Sonoma, Inc (NYSE: WSM)is backto breakeven:

  • [By Peter Graham]

    A long term performance chart shows mid cap Bed Bath & Beyond in a steady decline since early 2015 while and small capPier 1 Imports Inc (NYSE: PIR)has performed worst, mid capRestoration Hardware Holdings Inc (NYSE: RH) is back up andmid capWilliams-Sonoma, Inc (NYSE: WSM)has drifted lower:

Top 5 Blue Chip Stocks To Buy Right Now: Facebook, Inc.(FB)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Among the others in the fray are Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), with a market cap of $650.77 billion, Microsoft Corporation (NASDAQ: MSFT) ($536.62 million) and Facebook Inc (NASDAQ: FB) ($433.95 million).

  • [By Evan Niu, CFA]

    Censorship is almost always a touchy subject, but it’s also par for the course in certain parts of the world. Just as Facebook (NASDAQ:FB) is now coming to grips with its own power and responsibility over what information people see, it seems that the company is starting to flirt a little bit with censorship.

  • [By Lee Jackson]

    Facebook Inc. (NASDAQ: FB) had another tech industry giant selling stock recently, The Chief Operating Officer Sheryl Sandberg sold a total of 109,000 shares at $117.65 apiece. The total proceeds from her trade was set at $12,824,074. The stock wastrading at $115.o5 on Friday’s close. The 52-week range for the social media conglomerate is $89.37 to $133.50, and the consensus price target is $155.56.